fluoxetine has been researched along with Anterior Choroidal Artery Infarction in 12 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty four patients suffered from the depression after acute cerebral infarction were randomly divided into three groups: depression control group, fluoxetine treated group and Jieyu Huoxue Decoction treated group." | 5.11 | [Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction]. ( Feng, BL; Li, ZY; Wang, QC, 2004) |
| "Fluoxetine was injected intraperitoneally in a dose of 20 mg/kg for 10 days after surgery." | 1.48 | Effects of Fluoxetine on Hippocampal Neurogenesis and Neuroprotection in the Model of Global Cerebral Ischemia in Rats. ( Chernysheva, G; Khodanovich, M; Kisel, A; Krutenkova, E; Kudabaeva, M; Plotnikov, M; Smolyakova, V; Wasserlauf, I; Yarnykh, V, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khodanovich, M | 1 |
| Kisel, A | 1 |
| Kudabaeva, M | 1 |
| Chernysheva, G | 1 |
| Smolyakova, V | 1 |
| Krutenkova, E | 1 |
| Wasserlauf, I | 1 |
| Plotnikov, M | 1 |
| Yarnykh, V | 1 |
| Xiao, W | 1 |
| Zhang, XB | 1 |
| Hu, HX | 1 |
| Wang, Z | 1 |
| Guo, XL | 1 |
| Brunkhorst, R | 1 |
| Friedlaender, F | 1 |
| Ferreirós, N | 1 |
| Schwalm, S | 1 |
| Koch, A | 1 |
| Grammatikos, G | 1 |
| Toennes, S | 1 |
| Foerch, C | 1 |
| Pfeilschifter, J | 1 |
| Pfeilschifter, W | 1 |
| He, W | 1 |
| Cai, D | 1 |
| Lin, L | 1 |
| Fang, Y | 1 |
| Zheng, X | 1 |
| Feng, BL | 1 |
| Wang, QC | 1 |
| Li, ZY | 1 |
| Zhao, CS | 1 |
| Puurunen, K | 1 |
| Schallert, T | 1 |
| Sivenius, J | 1 |
| Jolkkonen, J | 1 |
| Lauterbach, EC | 2 |
| Price, ST | 1 |
| Spears, TE | 1 |
| Jackson, JG | 1 |
| Kirsh, AD | 1 |
| Stamenkovic, M | 1 |
| Schindler, S | 1 |
| Kasper, S | 1 |
| Arya, DK | 1 |
| Low, BL | 1 |
| Chong, SA | 1 |
| Brown, KW | 1 |
| Sloan, RL | 1 |
| Pentland, B | 1 |
4 trials available for fluoxetine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
[Acupuncture and drug for subcortical ischemic vascular disease complicated with depression: a randomized controlled trial].
Topics: Acupuncture Points; Acupuncture Therapy; Adult; Aged; Cerebral Infarction; Depression; Female; Fluox | 2014 |
Clinical studies on event-related potentials (ERPs) N400 and the related factors in patients with poststroke depression (PSD).
Topics: Aged; Antidepressive Agents, Second-Generation; Blood Platelets; Cerebral Hemorrhage; Cerebral Infar | 2010 |
[Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction].
Topics: Aged; Antidepressive Agents, Second-Generation; Cerebral Infarction; Depression; Drugs, Chinese Herb | 2004 |
Fluoxetine as a treatment for post-stroke emotionalism.
Topics: Aged; Antidepressive Agents; Cerebral Infarction; Double-Blind Method; Female; Fluoxetine; Humans; M | 1998 |
8 other studies available for fluoxetine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Effects of Fluoxetine on Hippocampal Neurogenesis and Neuroprotection in the Model of Global Cerebral Ischemia in Rats.
Topics: Animals; Cerebral Infarction; Fluoxetine; Hippocampus; Male; Neurogenesis; Neuroprotective Agents; R | 2018 |
Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.
Topics: Animals; Ceramides; Cerebral Cortex; Cerebral Infarction; Enzyme Inhibitors; Fluoxetine; Intracrania | 2015 |
Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury.
Topics: Affect; Aggression; Aging; Animals; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; B | 2005 |
Serotonin responsive and nonresponsive diurnal depressive mood disorders and pathological affect in thalamic infarct associated with myoclonus and blepharospasm.
Topics: Blepharospasm; Cerebral Infarction; Circadian Rhythm; Depressive Disorder; Female; Fluoxetine; Human | 1994 |
Fluoxetine withdrawal and thalamic pain.
Topics: Cerebral Infarction; Depression; Female; Fluoxetine; Humans; Middle Aged; Pain; Thalamus; Time Facto | 1994 |
[Therapy of post-stroke depression with fluoxetine. A pilot project].
Topics: Aged; Antidepressive Agents, Second-Generation; Cerebral Infarction; Depressive Disorder; Female; Fl | 1996 |
Existing brain condition may predispose to SSRI-induced extrapyramidal symptoms.
Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Bipolar Disorder; Cerebral Infarction; Female; Fluo | 1997 |
Treating poststroke pathologic crying with fluoxetine.
Topics: Cerebral Infarction; Crying; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake I | 1998 |